Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation

Federica Sora', Patrizia Chiusolo, Luca Laurenti, Gina Zini, Simona Sica, Elisabetta Metafuni, Silvia Bellesi, Sabrina Giammarco, Giuseppe Ausoni, Giuseppe Leone, Aj Bayer, B Mario

Research output: Contribution to journal › Article

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences